Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Breast Cancer
    July 2021
  1. QIAO Y, van Londen GJ, Brufsky JW, Poppenberg JT, et al
    Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: a randomized clinical trial.
    Breast Cancer. 2021 Jul 30. pii: 10.1007/s12282-021-01278.
    >> Share

  2. TAKAHASHI S, Fukui T, Nomizu T, Kakugawa Y, et al
    TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients.
    Breast Cancer. 2021 Jul 24. pii: 10.1007/s12282-021-01250.
    >> Share

  3. UEMOTO Y, Uchida M, Kondo N, Wanifuchi-Endo Y, et al
    Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery.
    Breast Cancer. 2021 Jul 22. pii: 10.1007/s12282-021-01275.
    >> Share

  4. GASTERATOS K, Morsi-Yeroyannis A, Vlachopoulos NC, Spyropoulou GA, et al
    Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes.
    Breast Cancer. 2021 Jul 12. pii: 10.1007/s12282-021-01274.
    >> Share

  5. SANGHA MS, Baker R, Ahmed M
    Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis.
    Breast Cancer. 2021 Jul 9. pii: 10.1007/s12282-021-01273.
    >> Share

  6. TOYODA Y, Katanoda K, Ishii K, Yamamoto H, et al
    Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan.
    Breast Cancer. 2021 Jul 9. pii: 10.1007/s12282-021-01272.
    >> Share

  7. GIORELLO MB, Matas A, Marenco P, Davies KM, et al
    CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients.
    Breast Cancer. 2021 Jul 9. pii: 10.1007/s12282-021-01270.
    >> Share

  8. PHAM TM, Nguyen DK, Pham HM, Le DC, et al
    Average lifespan shortened due to breast cancer in Australia, 1990-2015.
    Breast Cancer. 2021 Jul 8. pii: 10.1007/s12282-021-01271.
    >> Share

    June 2021
  9. AMIOKA A, Kadoya T, Sueoka S, Kobayashi Y, et al
    Correction to: Effect of Wnt5a on drug resistance in estrogen receptorpositive breast cancer.
    Breast Cancer. 2021 Jun 28. pii: 10.1007/s12282-021-01268.
    >> Share

  10. PARKS RM, Alfarsi LH, Green AR, Cheung KL, et al
    Biology of primary breast cancer in older women beyond routine biomarkers.
    Breast Cancer. 2021 Jun 24. pii: 10.1007/s12282-021-01266.
    >> Share

  11. JOSHI A, Larkins S, Evans R, Moodley N, et al
    Use and impact of breast cancer survivorship care plans: a systematic review.
    Breast Cancer. 2021 Jun 19. pii: 10.1007/s12282-021-01267.
    >> Share

  12. GHOREISHY SM, Aminianfar A, Benisi-Kohansal S, Azadbakht L, et al
    Association between dietary phytochemical index and breast cancer: a case-control study.
    Breast Cancer. 2021 Jun 13. pii: 10.1007/s12282-021-01265.
    >> Share

  13. LIN Y, Xu Y, Wang C, Song Y, et al
    Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
    Breast Cancer. 2021 Jun 9. pii: 10.1007/s12282-021-01263.
    >> Share

    May 2021
  14. AMIOKA A, Kadoya T, Sueoka S, Kobayashi Y, et al
    Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer.
    Breast Cancer. 2021 May 28. pii: 10.1007/s12282-021-01241.
    >> Share

  15. INOKUCHI M, Kutomi G, Kijima Y, Sakai T, et al
    Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01256.
    >> Share

  16. YAMAUCHI C, Yoshimura M, Sekiguchi K, Hamamoto Y, et al
    Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01255.
    >> Share

  17. IWATA H, Saji S, Ikeda M, Inokuchi M, et al
    Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01253.
    >> Share

  18. UEMATSU T, Nakashima K, Kikuchi M, Kubota K, et al
    Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01251.
    >> Share

  19. WANG L, Li Q, Aushev VN, Neugut AI, et al
    PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study.
    Breast Cancer. 2021 May 18. pii: 10.1007/s12282-021-01261.
    >> Share

  20. PEARSON A, Dhillon HM, Kiely BE
    Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?
    Breast Cancer. 2021 May 11. pii: 10.1007/s12282-021-01260.
    >> Share

  21. CHEN XQ, Zhang F, Xiao FH, Peng Y, et al
    Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
    Breast Cancer. 2021 May 8. pii: 10.1007/s12282-021-01262.
    >> Share

  22. CHAO X, Tan W, Tsang JY, Tse GM, et al
    Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases.
    Breast Cancer. 2021 May 3. pii: 10.1007/s12282-021-01246.
    >> Share

  23. VILLASCO A, Accomasso F, D'Alonzo M, Agnelli F, et al
    Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer patients.
    Breast Cancer. 2021 May 3. pii: 10.1007/s12282-021-01258.
    >> Share

    April 2021
  24. HIRATA K, Narabayashi M, Hanai Y, Fukumoto K, et al
    Comparison of thoracic and abdominal deep inspiration breath holds in whole-breast irradiation for patients with left-sided breast cancer.
    Breast Cancer. 2021 Apr 28. pii: 10.1007/s12282-021-01259.
    >> Share

  25. SHIMOI T, Nagai SE, Yoshinami T, Takahashi M, et al
    Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
    Breast Cancer. 2021 Apr 22. pii: 10.1007/s12282-021-01252.
    >> Share

  26. ADACHI Y, Oze I, Sawaki M, Hattori M, et al
    Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer.
    Breast Cancer. 2021 Apr 22. pii: 10.1007/s12282-021-01245.
    >> Share

  27. OZAKI A, Tachibana K, Ohtake T
    Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to "A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Ja
    Breast Cancer. 2021 Apr 20. pii: 10.1007/s12282-021-01254.
    >> Share

  28. NAGASAKI E, Kudo R, Tamura M, Hayashi K, et al
    Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report.
    Breast Cancer. 2021 Apr 11. pii: 10.1007/s12282-021-01240.
    >> Share

  29. KONISHI T, Fujiogi M, Michihata N, Morita K, et al
    Comparisons of postoperative outcomes after breast cancer surgery in patients with and without renal replacement therapy: a matched-pair cohort study using a Japanese nationwide inpatient database.
    Breast Cancer. 2021 Apr 10. pii: 10.1007/s12282-021-01248.
    >> Share

  30. PAPPOT H, Baeksted CW, Nissen A, Knoop A, et al
    Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study.
    Breast Cancer. 2021 Apr 9. pii: 10.1007/s12282-021-01244.
    >> Share

  31. ZHANG J, Tian Q, Zhang M, Wang H, et al
    Immune-related biomarkers in triple-negative breast cancer.
    Breast Cancer. 2021 Apr 9. pii: 10.1007/s12282-021-01247.
    >> Share

  32. SONG C, Lowe VJ, Lee S
    Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC).
    Breast Cancer. 2021 Apr 3. pii: 10.1007/s12282-021-01242.
    >> Share

  33. FUTAMURA M, Oba M, Masuda N, Bando H, et al
    Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).
    Breast Cancer. 2021 Apr 3. pii: 10.1007/s12282-021-01238.
    >> Share

  34. TAKADA M, Tanaka G, Hashimoto H, Hirai Y, et al
    Practical approach to prevent COVID-19 infection at breast cancer screening.
    Breast Cancer. 2021 Apr 2. pii: 10.1007/s12282-021-01235.
    >> Share

  35. INOUE K, Masuda N, Iwata H, Takahashi M, et al
    Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.
    Breast Cancer. 2021 Apr 1. pii: 10.1007/s12282-021-01239.
    >> Share

    March 2021
  36. NAHVIJOU A, Safari H, Ameri H
    Correction to: Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population.
    Breast Cancer. 2021 Mar 26. pii: 10.1007/s12282-021-01243.
    >> Share

  37. DU L, Tao X, Shen X
    Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway.
    Breast Cancer. 2021 Mar 26. pii: 10.1007/s12282-021-01218.
    >> Share

  38. SASADA S, Masumoto N, Emi A, Kadoya T, et al
    Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis.
    Breast Cancer. 2021 Mar 19. pii: 10.1007/s12282-021-01236.
    >> Share

  39. BARZGAR BAROUGH N, Sajjadian F, Jalilzadeh N, Shafaei H, et al
    Understanding breast cancer heterogeneity through non-genetic heterogeneity.
    Breast Cancer. 2021 Mar 15. pii: 10.1007/s12282-021-01237.
    >> Share

  40. VINH-HUNG V, Everaert H, Gorobets O, Van Parijs H, et al
    Breast cancer preoperative (18)FDG-PET, overall survival prognostic separation compared with the lymph node ratio.
    Breast Cancer. 2021 Mar 10. pii: 10.1007/s12282-021-01234.
    >> Share

  41. WANG LF, Eaglehouse YL, Poppenberg JT, Brufsky JW, et al
    Effects of a personal trainer-led exercise intervention on physical activity, physical function, and quality of life of breast cancer survivors.
    Breast Cancer. 2021 Mar 10. pii: 10.1007/s12282-020-01211.
    >> Share

  42. TAN PY, Teng KT
    Role of dietary fat on obesity-related postmenopausal breast cancer: insights from mouse models and methodological considerations.
    Breast Cancer. 2021 Mar 9. pii: 10.1007/s12282-021-01233.
    >> Share

  43. TAKAHASHI M, Inoue K, Mukai H, Yamanaka T, et al
    Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan.
    Breast Cancer. 2021 Mar 7. pii: 10.1007/s12282-021-01232.
    >> Share

  44. NAHVIJOU A, Safari H, Ameri H
    Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population.
    Breast Cancer. 2021 Mar 5. pii: 10.1007/s12282-021-01230.
    >> Share

    February 2021
  45. KUREBAYASHI J, Shiba E, Toyama T, Matsumoto H, et al
    A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-respons
    Breast Cancer. 2021 Feb 27. pii: 10.1007/s12282-020-01205.
    >> Share

  46. KURODA H, Jamiyan T, Yamaguchi R, Kakumoto A, et al
    Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer.
    Breast Cancer. 2021 Feb 25. pii: 10.1007/s12282-021-01227.
    >> Share

  47. KAWATE T, Yoshida A, Sugae S, Asaga S, et al
    Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society.
    Breast Cancer. 2021 Feb 20. pii: 10.1007/s12282-020-01214.
    >> Share

  48. OHARA A, Naoi Y, Shimoda M, Tanei T, et al
    Impact of tumor cellularity on the HER2 amplification assay by OncoScan in breast cancer.
    Breast Cancer. 2021 Feb 16. pii: 10.1007/s12282-021-01226.
    >> Share

  49. PARK S, Jeong J, Han W, Lee YJ, et al
    Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society.
    Breast Cancer. 2021 Feb 14. pii: 10.1007/s12282-021-01223.
    >> Share

  50. ZHANG Y, Tian J, Qu C, Peng Y, et al
    Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
    Breast Cancer. 2021 Feb 10. pii: 10.1007/s12282-021-01221.
    >> Share

  51. OCHI T, Tsunoda H, Matsuda N, Nozaki F, et al
    Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer.
    Breast Cancer. 2021 Feb 9. pii: 10.1007/s12282-021-01220.
    >> Share

  52. QUI S, Takeshita T, Sueta A, Tomiguchi M, et al
    Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum.
    Breast Cancer. 2021 Feb 4. pii: 10.1007/s12282-020-01212.
    >> Share

    January 2021
  53. TANAKA Y, Ohno T, Kadonaga T, Kidokoro Y, et al
    Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
    Breast Cancer. 2021 Jan 22. pii: 10.1007/s12282-021-01217.
    >> Share

  54. OHNUKI K, Tohno E, Tsunoda H, Uematsu T, et al
    Correction to: Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan.
    Breast Cancer. 2021 Jan 21. pii: 10.1007/s12282-021-01216.
    >> Share

  55. LIU X, Chang Q, Wang H, Qian H, et al
    Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
    Breast Cancer. 2021 Jan 21. pii: 10.1007/s12282-021-01215.
    >> Share

  56. SONG BI
    A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
    Breast Cancer. 2021 Jan 17. pii: 10.1007/s12282-020-01202.
    >> Share

  57. CHEN Y, Noma S, Taguchi Y, Takahashi M, et al
    Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan.
    Breast Cancer. 2021 Jan 16. pii: 10.1007/s12282-020-01207.
    >> Share

  58. HSUEH EJ, Loh EW, Lin JJ, Tam KW, et al
    Effects of yoga on improving quality of life in patients with breast cancer: a meta-analysis of randomized controlled trials.
    Breast Cancer. 2021 Jan 15. pii: 10.1007/s12282-020-01209.
    >> Share

  59. SHIRDARREH M, Pezo RC
    Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review.
    Breast Cancer. 2021 Jan 11. pii: 10.1007/s12282-020-01213.
    >> Share

  60. NEDELJKOVIC M, Tanic N, Prvanovic M, Milovanovic Z, et al
    Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer.
    Breast Cancer. 2021 Jan 8. pii: 10.1007/s12282-020-01210.
    >> Share

  61. CAO W, Jiang Y, Ji X, Ma L, et al
    An immune-related risk gene signature predicts the prognosis of breast cancer.
    Breast Cancer. 2021 Jan 5. pii: 10.1007/s12282-020-01201.
    >> Share

  62. YEN TWF, Garacci Z, Laud PW, Pezzin LE, et al
    Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer.
    Breast Cancer. 2021 Jan 4. pii: 10.1007/s12282-020-01206.
    >> Share

  63. OEI SL, Thronicke A, Matthes H, Schad F, et al
    Assessment of integrative non-pharmacological interventions and quality of life in breast cancer patients using real-world data.
    Breast Cancer. 2021 Jan 3. pii: 10.1007/s12282-020-01193.
    >> Share

  64. MIYAKE T, Shimoda M, Tanei T, Kagara N, et al
    Sentinel lymph node biopsy after introducing Twirl(R) breast markers into suspicious lymph nodes in breast cancer patients.
    Breast Cancer. 2021 Jan 3. pii: 10.1007/s12282-020-01195.
    >> Share

  65. YAMAGUCHI K, Hara Y, Kitano I, Hamamoto T, et al
    Relationship between MRI findings and invasive breast cancer with podoplanin-positive cancer-associated fibroblasts.
    Breast Cancer. 2021 Jan 3. pii: 10.1007/s12282-020-01198.
    >> Share

  66. WANG H, Zhang S, Yee D, Basu S, et al
    Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis.
    Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01194.
    >> Share

  67. CHEN J, Zhang X, Lu Y, Zhang T, et al
    Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis.
    Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01196.
    >> Share

  68. YOKOE T, Kurozumi S, Nozawa K, Ozaki Y, et al
    Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B).
    Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01192.
    >> Share

  69. FUJISAWA F, Kunimasa K, Kano-Fujiwara R, Sato Y, et al
    STK11 loss drives rapid progression in a breast cancer patient resulting in pulmonary tumor thrombotic microangiopathy.
    Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01200.
    >> Share

  70. OHNUKI K, Tohno E, Tsunoda H, Uematsu T, et al
    Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan.
    Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01203.
    >> Share

  71. MICHA AE, Sinnett V, Downey K, Allen S, et al
    Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.
    Breast Cancer. 2021;28:196-205.
    >> Share

  72. YAGHOUBI S, Gharibi T, Karimi MH, Sadeqi Nezhad M, et al
    Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs).
    Breast Cancer. 2021;28:216-225.
    >> Share

  73. WEI Y, Li H, Qu Q
    miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers.
    Breast Cancer. 2021;28:175-186.
    >> Share

  74. ZHAO H
    The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Breast Cancer. 2021;28:187-195.
    >> Share

  75. BOLAND MR, Nugent T, Nolan J, O'Mahony J, et al
    Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature.
    Breast Cancer. 2021;28:168-174.
    >> Share

  76. ZHAO W, Tian Q, Zhao A, Wang B, et al
    The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
    Breast Cancer. 2021;28:110-118.
    >> Share

  77. NAHVIJOU A, Safari H, Yousefi M, Rajabi M, et al
    Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.
    Breast Cancer. 2021;28:130-136.
    >> Share

  78. SECOMBE KR, Ball IA, Shirren J, Wignall AD, et al
    Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant.
    Breast Cancer. 2021;28:99-109.
    >> Share

    December 2020
  79. SHAFEI MA, Flemban A, Daly C, Kendrick P, et al
    Differential expression of the BCAT isoforms between breast cancer subtypes.
    Breast Cancer. 2020 Dec 24. pii: 10.1007/s12282-020-01197.
    >> Share

    November 2020
  80. MU G, Ji H, He H, Wang H, et al
    Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
    Breast Cancer. 2020 Nov 27. pii: 10.1007/s12282-020-01191.
    >> Share

  81. WANG B, Yan T, Sun L, Zhang G, et al
    A history of severe nausea and vomiting during pregnancy predicts a higher incidence of postoperative nausea and vomiting after breast cancer surgery without breast reconstruction.
    Breast Cancer. 2020 Nov 26. pii: 10.1007/s12282-020-01190.
    >> Share

  82. WU X, Zhang X, Hao Y, Li J, et al
    Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews.
    Breast Cancer. 2020 Nov 25. pii: 10.1007/s12282-020-01182.
    >> Share

  83. SAWAKI M, Yamada A, Kumamaru H, Miyata H, et al
    Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan.
    Breast Cancer. 2020 Nov 21. pii: 10.1007/s12282-020-01188.
    >> Share

  84. KAWADA K, Taira N, Mizoo T, Suzuki Y, et al
    Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
    Breast Cancer. 2020 Nov 13. pii: 10.1007/s12282-020-01185.
    >> Share

  85. NOGUCHI M, Inokuchi M, Noguchi M, Morioka E, et al
    Axillary surgery for breast cancer: past, present, and future.
    Breast Cancer. 2020 Nov 9. pii: 10.1007/s12282-020-01120.
    >> Share

  86. BAN K, Tsunoda H, Togashi S, Kawaguchi Y, et al
    Breast cancer screening using digital breast tomosynthesis compared to digital mammography alone for Japanese women.
    Breast Cancer. 2020 Nov 9. pii: 10.1007/s12282-020-01180.
    >> Share

  87. YU X, Guo J, Zhou Q, Huang W, et al
    A novel immune-related prognostic index for predicting breast cancer overall survival.
    Breast Cancer. 2020 Nov 4. pii: 10.1007/s12282-020-01175.
    >> Share

  88. TANG L, Ma Z, Ishikawa Y, Matsushita H, et al
    Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan.
    Breast Cancer. 2020 Nov 3. pii: 10.1007/s12282-020-01181.
    >> Share

    October 2020
  89. PRIYADARSHINI R, Raj GM, Sundaram R, Kayal S, et al
    Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo-adjuvant chemotherapy.
    Breast Cancer. 2020 Oct 30. pii: 10.1007/s12282-020-01177.
    >> Share

  90. SAKAMOTO N, Nashimoto M, Nakagawa M, Haruyama Y, et al
    Skin grafting utilizing a skin of lateral thoracic area for chest wall reconstruction in patient who underwent mastectomy for locally advanced breast cancer.
    Breast Cancer. 2020 Oct 30. pii: 10.1007/s12282-020-01173.
    >> Share

  91. SHIMA H, Okuno T, Nakamura T, Noro A, et al
    Comparing the extent of breast cancer tumors through contrast-enhanced ultrasound vs B-mode, opposed with pathology: evergreen study.
    Breast Cancer. 2020 Oct 29. pii: 10.1007/s12282-020-01176.
    >> Share

  92. PENG R, Cao J, Guo Q, Sun Q, et al
    Variant in BCAR4 gene correlated with the breast cancer susceptibility and mRNA expression of lncRNA BCAR4 in Chinese Han population.
    Breast Cancer. 2020 Oct 28. pii: 10.1007/s12282-020-01174.
    >> Share

  93. LIAN B, Li H, Liu Y, Chai D, et al
    Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
    Breast Cancer. 2020 Oct 27. pii: 10.1007/s12282-020-01179.
    >> Share

  94. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Analysis of subsequent therapy in Japanese patients with hormone receptorpositive/human epidermal growth factor receptor 2negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3.
    Breast Cancer. 2020 Oct 21. pii: 10.1007/s12282-020-01162.
    >> Share

  95. LIANG H, Zhou G, Lv L, Lu J, et al
    KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
    Breast Cancer. 2020 Oct 16. pii: 10.1007/s12282-020-01170.
    >> Share

  96. LING Y, Cao Q, Liu Y, Zhao J, et al
    Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
    Breast Cancer. 2020 Oct 12. pii: 10.1007/s12282-020-01169.
    >> Share

  97. LAO C, Kuper-Hommel M, Elwood M, Campbell I, et al
    Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
    Breast Cancer. 2020 Oct 12. pii: 10.1007/s12282-020-01171.
    >> Share

  98. HSU YH, Chen VC, Hsieh CC, Weng YP, et al
    Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
    Breast Cancer. 2020 Oct 8. pii: 10.1007/s12282-020-01168.
    >> Share

    September 2020
  99. BANDEIRA G, Rocha K, Lazar M, Ezquina S, et al
    Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
    Breast Cancer. 2020 Sep 28. pii: 10.1007/s12282-020-01165.
    >> Share

  100. ONISHI N, Kataoka M
    Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.
    Breast Cancer. 2020 Sep 21. pii: 10.1007/s12282-020-01157.
    >> Share

  101. AHMED M
    Optimizing breast cancer surgery during the COVID-19 pandemic.
    Breast Cancer. 2020 Sep 18. pii: 10.1007/s12282-020-01160.
    >> Share

  102. ZHAO JM, An Q, Sun CN, Li YB, et al
    Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
    Breast Cancer. 2020 Sep 17. pii: 10.1007/s12282-020-01158.
    >> Share

  103. FUJII T, Ichiba K, Honda C, Tokuda S, et al
    Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
    Breast Cancer. 2020 Sep 17. pii: 10.1007/s12282-020-01161.
    >> Share

  104. VUKSANOVIC D, Sanmugarajah J, Lunn D, Sawhney R, et al
    Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project.
    Breast Cancer. 2020 Sep 14. pii: 10.1007/s12282-020-01156.
    >> Share

  105. ALATAWI Y, Hansen RA, Chou C, Qian J, et al
    The impact of cognitive impairment on survival and medication adherence among older women with breast cancer.
    Breast Cancer. 2020 Sep 9. pii: 10.1007/s12282-020-01155.
    >> Share

  106. AKRIDA I, Argentou MI
    Correction to: Letter to the Editor: comment on 'Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective' by Elfgen et al.
    Breast Cancer. 2020 Sep 8. pii: 10.1007/s12282-020-01154.
    >> Share

  107. ROGOZA-JANISZEWSKA E, Malinska K, Gorski B, Scott RJ, et al
    Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.
    Breast Cancer. 2020 Sep 4. pii: 10.1007/s12282-020-01151.
    >> Share

  108. AHMED M
    Beyond the speed of SOUND.
    Breast Cancer. 2020;27:793-795.
    >> Share

  109. TOMITA M, Oura S, Nishiguchi H, Makimoto S, et al
    A case of bilateral methotrexate-associated diffuse large B-cell lymphomas of the breasts with unique clinical presentation and outcome.
    Breast Cancer. 2020;27:1038-1043.
    >> Share

  110. YAMAGUCHI M, Takagi K, Sato A, Miki Y, et al
    Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance.
    Breast Cancer. 2020;27:919-928.
    >> Share

  111. IIDA M, Toyosawa D, Nakamura M, Tsuboi K, et al
    Decreased ER dependency after acquired resistance to CDK4/6 inhibitors.
    Breast Cancer. 2020;27:963-972.
    >> Share

  112. JAMIYAN T, Kuroda H, Yamaguchi R, Nakazato Y, et al
    Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast.
    Breast Cancer. 2020;27:880-892.
    >> Share

  113. CHOI H, Noh H, Cho IJ, Lim ST, et al
    Changes in neutrophil to lymphocyte ratio (NLR) during neoadjuvant treatment correlated with patients' survival.
    Breast Cancer. 2020;27:871-879.
    >> Share

  114. CORADINI D, Gambazza S, Oriana S, Ambrogi F, et al
    Body mass index and gamma-glutamyl transferase expression in normal and cancerous breast tissue.
    Breast Cancer. 2020;27:850-860.
    >> Share

    August 2020
  115. OGATA R, Kishino E, Saitoh W, Koike Y, et al
    Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.
    Breast Cancer. 2020 Aug 28. pii: 10.1007/s12282-020-01150.
    >> Share

  116. LOPEZ P, Galvao DA, Taaffe DR, Newton RU, et al
    Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage.
    Breast Cancer. 2020 Aug 19. pii: 10.1007/s12282-020-01147.
    >> Share

  117. ISHIDA K, Ohnuki K, Usami S, Komatsu H, et al
    A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan.
    Breast Cancer. 2020 Aug 13. pii: 10.1007/s12282-020-01144.
    >> Share

  118. ZHONG W, Yang Y, Zhang A, Lin W, et al
    Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer.
    Breast Cancer. 2020 Aug 11. pii: 10.1007/s12282-020-01142.
    >> Share

    July 2020
  119. IOANNA A, Maria-Ioanna A
    Letter to the Editor: comment on 'Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective' by Elfgen et al.
    Breast Cancer. 2020 Jul 31. pii: 10.1007/s12282-020-01143.
    >> Share

  120. VANNI G, Pellicciaro M, Materazzo M, Dauri M, et al
    Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency.
    Breast Cancer. 2020 Jul 30. pii: 10.1007/s12282-020-01137.
    >> Share

  121. WAAIJER L, Filipe MD, Simons J, van der Pol CC, et al
    Detection of breast cancer precursor lesions by autofluorescence ductoscopy.
    Breast Cancer. 2020 Jul 28. pii: 10.1007/s12282-020-01136.
    >> Share

  122. YOSHIDA-ICHIKAWA Y, Horimoto Y, Shikama N, Yanagisawa N, et al
    Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
    Breast Cancer. 2020 Jul 27. pii: 10.1007/s12282-020-01134.
    >> Share

  123. YAMAMOTO Y, Yamashiro H, Toh U, Kondo N, et al
    Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
    Breast Cancer. 2020 Jul 26. pii: 10.1007/s12282-020-01138.
    >> Share

  124. MISIR S, Hepokur C, Aliyazicioglu Y, Enguita FJ, et al
    Circular RNAs serve as miRNA sponges in breast cancer.
    Breast Cancer. 2020 Jul 26. pii: 10.1007/s12282-020-01140.
    >> Share

  125. HAYASHI N, Kumamaru H, Isozumi U, Aogi K, et al
    Annual report of the Japanese Breast Cancer Registry for 2017.
    Breast Cancer. 2020 Jul 24. pii: 10.1007/s12282-020-01139.
    >> Share

  126. MOSS JL, Tatalovich Z, Zhu L, Morgan C, et al
    Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors.
    Breast Cancer. 2020 Jul 15. pii: 10.1007/s12282-020-01132.
    >> Share

  127. YANG KL, Khoo BY, Ong MT, Yoong ICK, et al
    In vitro anti-breast cancer studies of LED red light therapy through autophagy.
    Breast Cancer. 2020 Jul 11. pii: 10.1007/s12282-020-01128.
    >> Share

  128. OKAZAKI M, Bando H, Tohno E, Kujiraoka Y, et al
    Investigation of the significance of population-based breast cancer screening among women aged under 40 years.
    Breast Cancer. 2020 Jul 8. pii: 10.1007/s12282-020-01131.
    >> Share

  129. TOZAKI M, Nakamura S
    Current status of breast cancer screening in high-risk women in Japan.
    Breast Cancer. 2020 Jul 6. pii: 10.1007/s12282-020-01103.
    >> Share

  130. ADACHI Y, Okumura S, Sawaki M, Hattori M, et al
    Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.
    Breast Cancer. 2020;27:716-723.
    >> Share

  131. CHANG YK, Chen CT, Wang M, Yang Y, et al
    Could ductoscopy alleviate the need of microdochectomy in pathological nipple discharge?
    Breast Cancer. 2020;27:607-612.
    >> Share

  132. ZAHA H, Motonari T, Abe N, Unesoko M, et al
    Fat necrosis in level I oncoplastic breast-conserving surgery focusing on a modified round block technique.
    Breast Cancer. 2020;27:567-572.
    >> Share

    June 2020
  133. CHONG F, Wang Y, Song M, Sun Q, et al
    Sedentary behavior and risk of breast cancer: a dose-response meta-analysis from prospective studies.
    Breast Cancer. 2020 Jun 30. pii: 10.1007/s12282-020-01126.
    >> Share

  134. TAJIRI W, Ijichi H, Takizawa K, Koi Y, et al
    The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
    Breast Cancer. 2020 Jun 29. pii: 10.1007/s12282-020-01130.
    >> Share

  135. TANAKA N, Hirano A, Hattori A, Ogura K, et al
    Effect of adjuvant chemotherapy in patients with ER + /HER2- breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01125.
    >> Share

  136. BANDO H, Kataoka A, Tamaki K, Kobayashi M, et al
    Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01118.
    >> Share

  137. BARTOLO A, Neves M, Carvalho B, Reis S, et al
    Fertility under uncertainty: exploring differences in fertility-related concerns and psychosocial aspects between breast cancer survivors and non-cancer infertile women.
    Breast Cancer. 2020 Jun 24. pii: 10.1007/s12282-020-01124.
    >> Share

  138. KAJIHARA N, Kitagawa F, Kobayashi T, Wada H, et al
    Interleukin-34 contributes to poor prognosis in triple-negative breast cancer.
    Breast Cancer. 2020 Jun 23. pii: 10.1007/s12282-020-01123.
    >> Share

  139. MALIK SS, Zia A, Rashid S, Mubarik S, et al
    XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
    Breast Cancer. 2020 Jun 19. pii: 10.1007/s12282-020-01121.
    >> Share

  140. TANAKA R, Yamagishi Y, Koiwai T, Kono T, et al
    Comparison between AJCC 8th prognostic stage and UICC anatomical stage in patients with primary breast cancer: a single institutional retrospective study.
    Breast Cancer. 2020 Jun 3. pii: 10.1007/s12282-020-01115.
    >> Share

  141. LAMBERT M, Sabiston CM, Wrosch C, Brunet J, et al
    An investigation into socio-demographic-, health-, and cancer-related factors associated with cortisol and C-reactive protein levels in breast cancer survivors: a longitudinal study.
    Breast Cancer. 2020 Jun 1. pii: 10.1007/s12282-020-01113.
    >> Share

  142. ELFGEN C, Guth U, Gruber G, Birrer S, et al
    Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective.
    Breast Cancer. 2020 Jun 1. pii: 10.1007/s12282-020-01114.
    >> Share

    May 2020
  143. TOKUNAGA E, Ijichi H, Tajiri W, Masuda T, et al
    The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution.
    Breast Cancer. 2020 May 29. pii: 10.1007/s12282-020-01116.
    >> Share

  144. CANER A, Sadiqova A, Erdogan A, Namlises D, et al
    Targeting of antitumor immune responses with live-attenuated Leishmania strains in breast cancer model.
    Breast Cancer. 2020 May 29. pii: 10.1007/s12282-020-01112.
    >> Share

  145. DUAN S, Luo X, Zeng H, Zhan X, et al
    SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
    Breast Cancer. 2020 May 23. pii: 10.1007/s12282-020-01111.
    >> Share

  146. SUGIE T, Sato E, Miyashita M, Yamaguchi R, et al
    Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Breast Cancer. 2020 May 23. pii: 10.1007/s12282-020-01110.
    >> Share

  147. HORII R, Tsuda H, Masuda S, Sugita H, et al
    Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.
    Breast Cancer. 2020 May 21. pii: 10.1007/s12282-020-01108.
    >> Share

  148. TSUDA H, Tsugawa K, Akiyama F, Horii R, et al
    Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition).
    Breast Cancer. 2020 May 19. pii: 10.1007/s12282-020-01106.
    >> Share

  149. SHIZUKU M, Shibata M, Okumura M, Takeuchi D, et al
    Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases.
    Breast Cancer. 2020 May 15. pii: 10.1007/s12282-020-01109.
    >> Share

  150. KUBO M, Kumamaru H, Isozumi U, Miyashita M, et al
    Annual report of the Japanese Breast Cancer Society registry for 2016.
    Breast Cancer. 2020 May 11. pii: 10.1007/s12282-020-01081.
    >> Share

  151. IWAMOTO T, Fujisawa T, Shien T, Araki K, et al
    The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs.
    Breast Cancer. 2020 May 11. pii: 10.1007/s12282-020-01095.
    >> Share

  152. BALTRES A, Al Masry Z, Zemouri R, Valmary-Degano S, et al
    Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer.
    Breast Cancer. 2020 May 8. pii: 10.1007/s12282-020-01100.
    >> Share

  153. YUEN S, Monzawa S, Yanai S, Matsumoto H, et al
    The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images.
    Breast Cancer. 2020 May 6. pii: 10.1007/s12282-020-01105.
    >> Share

  154. KIM S, Lee S, Bae Y, Lee S, et al
    Nipple-sparing mastectomy for breast cancer close to the nipple: a single institution's 11-year experience.
    Breast Cancer. 2020 May 5. pii: 10.1007/s12282-020-01104.
    >> Share

  155. CHAO YH, Wang SY, Sheu SJ
    Integrative review of breast cancer survivors' transition experience and transitional care: dialog with transition theory perspectives.
    Breast Cancer. 2020 May 5. pii: 10.1007/s12282-020-01097.
    >> Share

  156. SEKINE H, Kijima Y, Kobayashi M, Itami J, et al
    Non-invasive quantitative measures of qualitative grading effectiveness as the indices of acute radiation dermatitis in breast cancer patients.
    Breast Cancer. 2020 May 3. pii: 10.1007/s12282-020-01082.
    >> Share

  157. XU Y, Zhang Z, Zhang L, Zhang C, et al
    Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co-expression network analysis.
    Breast Cancer. 2020 May 1. pii: 10.1007/s12282-020-01101.
    >> Share

  158. REINDERS FCJ, Young-Afat DA, Batenburg MCT, Bruekers SE, et al
    Higher reconstruction failure and less patient-reported satisfaction after post mastectomy radiotherapy with immediate implant-based breast reconstruction compared to immediate autologous breast reconstruction.
    Breast Cancer. 2020;27:435-444.
    >> Share

  159. OKAMOTO S, Chen ST, Covelli JD, DeMartini WB, et al
    High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.
    Breast Cancer. 2020;27:405-414.
    >> Share

  160. VAN EGDOM LSE, de Kock MA, Apon I, Mureau MAM, et al
    Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.
    Breast Cancer. 2020;27:426-434.
    >> Share

    April 2020
  161. TAKANO T
    The era of meta-analyses-based recommendations: how were the Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer established?
    Breast Cancer. 2020 Apr 27. pii: 10.1007/s12282-020-01099.
    >> Share

  162. LU Y, Yang G, Xiao Y, Zhang T, et al
    Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Breast Cancer. 2020 Apr 27. pii: 10.1007/s12282-020-01086.
    >> Share

  163. ALKARAKI A, Alshaer W, Wehaibi S, Gharaibeh L, et al
    Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and beta-catenin genes.
    Breast Cancer. 2020 Apr 23. pii: 10.1007/s12282-020-01098.
    >> Share

  164. DAN J, Tan J, Huang J, Zhang X, et al
    The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Breast Cancer. 2020 Apr 18. pii: 10.1007/s12282-020-01096.
    >> Share

  165. DENDA Y, Niikura N, Satoh-Kuriwada S, Yokoyama K, et al
    Taste alterations in patients with breast cancer following chemotherapy: a cohort study.
    Breast Cancer. 2020 Apr 16. pii: 10.1007/s12282-020-01089.
    >> Share

  166. TONG T, Lu H, Zong J, Lv Q, et al
    Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis.
    Breast Cancer. 2020 Apr 16. pii: 10.1007/s12282-020-01094.
    >> Share

  167. OSHIRO C, Yamasaki M, Noda Y, Nishimae A, et al
    Comparative evaluation of nuclear and histological grades as prognostic factors for invasive breast cancer.
    Breast Cancer. 2020 Apr 15. pii: 10.1007/s12282-020-01093.
    >> Share

  168. ISAKOVA JT, Vinnikov D, Kipen VN, Talaibekova ET, et al
    Gene-to-gene interactions and the association of TP53, XRCC1, TNFalpha, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females.
    Breast Cancer. 2020 Apr 15. pii: 10.1007/s12282-020-01092.
    >> Share

  169. PAN XF, Ma YJ, Tang Y, Yu MM, et al
    Breast cancer populations may have an increased prevalence of thyroglobulin antibody and thyroid peroxidase antibody: a systematic review and meta-analysis.
    Breast Cancer. 2020 Apr 11. pii: 10.1007/s12282-020-01078.
    >> Share

  170. AOISHI Y, Oura S, Nishiguchi H, Hirai Y, et al
    Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
    Breast Cancer. 2020 Apr 8. pii: 10.1007/s12282-020-01088.
    >> Share

  171. FARBOOD A, Sahmeddini MA, Bayat S, Karami N, et al
    The effect of preoperative depression and anxiety on heart rate variability in women with breast cancer.
    Breast Cancer. 2020 Apr 7. pii: 10.1007/s12282-020-01087.
    >> Share

  172. SHIMOI T, Nagai SE, Yoshinami T, Takahashi M, et al
    The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
    Breast Cancer. 2020 Apr 2. pii: 10.1007/s12282-020-01085.
    >> Share

    March 2020
  173. SOLIS-CASTILLO LA, Garcia-Romo GS, Diaz-Rodriguez A, Reyes-Hernandez D, et al
    Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.
    Breast Cancer. 2020 Mar 16. pii: 10.1007/s12282-020-01079.
    >> Share

  174. ZEHRA S, Doyle F, Barry M, Walsh S, et al
    Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis.
    Breast Cancer. 2020 Mar 12. pii: 10.1007/s12282-020-01076.
    >> Share

  175. TSUDA H
    Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition).
    Breast Cancer. 2020 Mar 9. pii: 10.1007/s12282-020-01074.
    >> Share

  176. KHALIS M, Dossus L, Rinaldi S, Biessy C, et al
    Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case-control study.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01072.
    >> Share

  177. WANG X, Zhou X, Zeng F, Wu X, et al
    miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01075.
    >> Share

  178. MATSUNUMA R, Watanabe T, Hozumi Y, Koizumi K, et al
    Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01077.
    >> Share

  179. GOTO Y, Tsugawa K, Furuya Y, Maezato M, et al
    Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey.
    Breast Cancer. 2020 Mar 5. pii: 10.1007/s12282-020-01071.
    >> Share

  180. MIYOSHI Y, Yoshimura Y, Saito K, Muramoto K, et al
    High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin-but not with treatment of physician's choice-in the EMBRACE study.
    Breast Cancer. 2020 Mar 5. pii: 10.1007/s12282-020-01067.
    >> Share

  181. OKUMURA S, Hyodo I, Iwata H, Kamei Y, et al
    Immediate one-stage implant-based breast reconstruction without the use of acellular dermal matrix in Japanese breast cancer patients.
    Breast Cancer. 2020 Mar 4. pii: 10.1007/s12282-020-01073.
    >> Share

  182. VURAL V, Yilmaz OC
    The Turkish SentiMAG feasibility trial: preliminary results.
    Breast Cancer. 2020;27:261-265.
    >> Share

  183. WADASADAWALA T, Sinha S, Parmar V, Verma S, et al
    Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: a prospective propensity score-matched pair analysis.
    Breast Cancer. 2020;27:206-212.
    >> Share

  184. SOROR T, Lancellotta V, Kovacs G, Lanzotti V, et al
    kOBCS((c)): a novel software calculator program of the Objective Breast Cosmesis Scale (OBCS).
    Breast Cancer. 2020;27:179-185.
    >> Share

    February 2020
  185. MANGONE L, Ferrari F, Mancuso P, Carrozzi G, et al
    Epidemiology and biological characteristics of male breast cancer in Italy.
    Breast Cancer. 2020 Feb 29. pii: 10.1007/s12282-020-01068.
    >> Share

  186. YAMAMOTO S, Masutani E, Arao H
    Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.
    Breast Cancer. 2020 Feb 29. pii: 10.1007/s12282-020-01062.
    >> Share

  187. JYLLING AMB, Jensen V, Lelkaitis G, Christiansen P, et al
    Male breast cancer: clinicopathological characterization of a National Danish cohort 1980-2009.
    Breast Cancer. 2020 Feb 27. pii: 10.1007/s12282-020-01066.
    >> Share

  188. MYOJIN M, Horimoto Y, Ito M, Kitano S, et al
    Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer.
    Breast Cancer. 2020 Feb 27. pii: 10.1007/s12282-020-01069.
    >> Share

  189. OHISHI Y, Mitsuda A, Ejima K, Morizono H, et al
    Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient.
    Breast Cancer. 2020 Feb 24. pii: 10.1007/s12282-020-01064.
    >> Share

  190. SEMAAN J, El-Hakim S, Ibrahim JN, Safi R, et al
    Comparative effect of sodium butyrate and sodium propionate on proliferation, cell cycle and apoptosis in human breast cancer cells MCF-7.
    Breast Cancer. 2020 Feb 24. pii: 10.1007/s12282-020-01063.
    >> Share

  191. SAFABAKHSH M, Imani H, Shab-Bidar S
    Higher dietary total antioxidant capacity is not associated with risk of breast cancer in Iranian women.
    Breast Cancer. 2020 Feb 17. pii: 10.1007/s12282-020-01059.
    >> Share

  192. YAMASHIRO H, Iwata H, Masuda N, Yamamoto N, et al
    Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.
    Breast Cancer. 2020 Feb 14. pii: 10.1007/s12282-020-01057.
    >> Share

  193. MILLER EA, Pinsky PF, Heckman-Stoddard BM, Minasian LM, et al
    Breast cancer risk prediction models and subsequent tumor characteristics.
    Breast Cancer. 2020 Feb 13. pii: 10.1007/s12282-020-01060.
    >> Share

  194. SASAKI M, Tozaki M, Rodriguez-Ruiz A, Yotsumoto D, et al
    Artificial intelligence for breast cancer detection in mammography: experience of use of the ScreenPoint Medical Transpara system in 310 Japanese women.
    Breast Cancer. 2020 Feb 12. pii: 10.1007/s12282-020-01061.
    >> Share

  195. SHIMOI T, Sagara Y, Hara F, Toyama T, et al
    First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
    Breast Cancer. 2020 Feb 11. pii: 10.1007/s12282-020-01054.
    >> Share

  196. LI J, Liu L, Feng Z, Wang X, et al
    Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study.
    Breast Cancer. 2020 Feb 10. pii: 10.1007/s12282-020-01058.
    >> Share

  197. MAROUFI NF, Vahedian V, Akbarzadeh M, Mohammadian M, et al
    The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-kappaB (NF-kappaB) and mitogen-activated protein kinase (MAPK) signaling pathways.
    Breast Cancer. 2020 Feb 5. pii: 10.1007/s12282-020-01055.
    >> Share

    January 2020
  198. GOHARA T, Komura M, Asano A, Emura T, et al
    A case of secretory breast cancer in a 6 year-old girl: is it possible to make a correct preoperative diagnosis?
    Breast Cancer. 2020 Jan 30. pii: 10.1007/s12282-020-01056.
    >> Share

  199. LINGRAND M, Lalonde S, Jutras-Carignan A, Bergeron KF, et al
    SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line.
    Breast Cancer. 2020 Jan 29. pii: 10.1007/s12282-020-01053.
    >> Share

  200. MIYASHITA M, Hattori M, Takano T, Toyama T, et al
    Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials.
    Breast Cancer. 2020 Jan 23. pii: 10.1007/s12282-020-01052.
    >> Share

  201. ZHANG Y, Li Z, Chen M, Chen H, et al
    lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
    Breast Cancer. 2020 Jan 20. pii: 10.1007/s12282-020-01048.
    >> Share

  202. HUANG M, Wu J, Ling R, Li N, et al
    Quadruple negative breast cancer.
    Breast Cancer. 2020 Jan 14. pii: 10.1007/s12282-020-01047.
    >> Share

  203. GOTO R, Hirota Y, Aruga T, Horiguchi S, et al
    The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer.
    Breast Cancer. 2020 Jan 13. pii: 10.1007/s12282-020-01049.
    >> Share

  204. LIU Y, Wang J, Su R, Tang Y, et al
    Postoperative radiotherapy-induced leiomyosarcoma in breast cancer: a case report and literature review.
    Breast Cancer. 2020 Jan 11. pii: 10.1007/s12282-020-01050.
    >> Share

  205. ZHANG L, Zhang X, Zhang H, Liu F, et al
    Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
    Breast Cancer. 2020 Jan 9. pii: 10.1007/s12282-020-01045.
    >> Share

  206. CHANG YK, Co M, Kwong A
    Conversion rate from mastectomy to breast conservation after neoadjuvant dual target therapy for HER2-positive breast cancer in the Asian population.
    Breast Cancer. 2020 Jan 8. pii: 10.1007/s12282-019-01037.
    >> Share

  207. YOSHINAMI T, Koizumi K, Nagai SE, Toyama T, et al
    Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition.
    Breast Cancer. 2020 Jan 8. pii: 10.1007/s12282-019-01039.
    >> Share

  208. KURATA K, Kubo M, Kai M, Mori H, et al
    Microsatellite instability in Japanese female patients with triple-negative breast cancer.
    Breast Cancer. 2020 Jan 6. pii: 10.1007/s12282-019-01043.
    >> Share

  209. ACUN T, Senses KM
    Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
    Breast Cancer. 2020 Jan 4. pii: 10.1007/s12282-019-01042.
    >> Share

  210. WANG B, Zhu L, He C, Tai M, et al
    Growth pattern can be used as a new characteristic to predict malignancy in breast cancer.
    Breast Cancer. 2020 Jan 3. pii: 10.1007/s12282-019-01041.
    >> Share

  211. BLOCKHUYS S, Brady DC, Wittung-Stafshede P
    Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01044.
    >> Share

  212. HE C, Kawaguchi K, Toi M
    DNA damage repair functions and targeted treatment in breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01038.
    >> Share

  213. TOPALOGLU US, Ozaslan E
    Comorbidity and polypharmacy in patients with breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01040.
    >> Share

  214. IZUMORI A, Kokubu Y, Sato K, Gomi N, et al
    Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities.
    Breast Cancer. 2020;27:129-139.
    >> Share

  215. YOU C, Zhang Y, Gu Y, Xiao Q, et al
    Comparison of the diagnostic performance of synthesized two-dimensional mammography and full-field digital mammography alone or in combination with digital breast tomosynthesis.
    Breast Cancer. 2020;27:47-53.
    >> Share

  216. NAGURA N, Hayashi N, Takei J, Yoshida A, et al
    Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
    Breast Cancer. 2020;27:70-76.
    >> Share

    December 2019
  217. LIAO W, Huang J, Wu Q, Wen F, et al
    First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis.
    Breast Cancer. 2019 Dec 18. pii: 10.1007/s12282-019-01034.
    >> Share

  218. INOKUCHI M, Kutomi G, Kijima Y, Sakai T, et al
    The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition.
    Breast Cancer. 2019 Dec 12. pii: 10.1007/s12282-019-01030.
    >> Share

  219. HASHEMI SM, Rafiemanesh H, Aghamohammadi T, Badakhsh M, et al
    Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis.
    Breast Cancer. 2019 Dec 11. pii: 10.1007/s12282-019-01031.
    >> Share

  220. KISHINO E, Ogata R, Saitoh W, Koike Y, et al
    Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.
    Breast Cancer. 2019 Dec 10. pii: 10.1007/s12282-019-01035.
    >> Share

  221. KAWAGUCHI H, Masuda N, Nakayama T, Aogi K, et al
    Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.
    Breast Cancer. 2019 Dec 6. pii: 10.1007/s12282-019-01029.
    >> Share

  222. KILLELEA BK, Herrin J, Soulos PR, Pollack CE, et al
    Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups.
    Breast Cancer. 2019 Dec 2. pii: 10.1007/s12282-019-01028.
    >> Share

    November 2019
  223. LIU H, Sun H, Zhang B, Liu S, et al
    (18)F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer.
    Breast Cancer. 2019 Nov 28. pii: 10.1007/s12282-019-01027.
    >> Share

  224. YANG JR, Shao YC
    Everolimus-associated cytomegalovirus colitis in a patient with metastasized breast cancer: a case report.
    Breast Cancer. 2019 Nov 26. pii: 10.1007/s12282-019-01026.
    >> Share

  225. IWATA H, Saji S, Ikeda M, Inokuchi M, et al
    The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient.
    Breast Cancer. 2019 Nov 22. pii: 10.1007/s12282-019-01021.
    >> Share

  226. UEMATSU T, Nakashima K, Kikuchi M, Kubota K, et al
    The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition.
    Breast Cancer. 2019 Nov 16. pii: 10.1007/s12282-019-01025.
    >> Share

  227. LI K, Pan WT, Ma YB, Xu XL, et al
    BMX activates Wnt/beta-catenin signaling pathway to promote cell proliferation and migration in breast cancer.
    Breast Cancer. 2019 Nov 14. pii: 10.1007/s12282-019-01024.
    >> Share

  228. MA J, Zhou Z
    Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer.
    Breast Cancer. 2019 Nov 13. pii: 10.1007/s12282-019-01022.
    >> Share

  229. LAI J, Hu S, Luo Y, Zheng R, et al
    Meta-analysis of deep inspiration breath hold (DIBH) versus free breathing (FB) in postoperative radiotherapy for left-side breast cancer.
    Breast Cancer. 2019 Nov 9. pii: 10.1007/s12282-019-01023.
    >> Share

  230. WANG X, Luo J, Jin K, Chen X, et al
    Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
    Breast Cancer. 2019 Nov 6. pii: 10.1007/s12282-019-01015.
    >> Share

  231. AKEZAKI Y, Nakata E, Kikuuchi M, Tominaga R, et al
    Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection.
    Breast Cancer. 2019 Nov 2. pii: 10.1007/s12282-019-01020.
    >> Share

    October 2019
  232. YAMAUCHI C, Yoshimura M, Sekiguchi K, Hamamoto Y, et al
    The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition.
    Breast Cancer. 2019 Oct 28. pii: 10.1007/s12282-019-01019.
    >> Share

  233. CHRISTENSEN TD, Buhl ASK, Christensen IJ, Buhl IK, et al
    Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.
    Breast Cancer. 2019 Oct 25. pii: 10.1007/s12282-019-01017.
    >> Share

  234. NISHIYAMA K, Taira N, Mizoo T, Kochi M, et al
    Influence of breast density on breast cancer risk: a case control study in Japanese women.
    Breast Cancer. 2019 Oct 24. pii: 10.1007/s12282-019-01018.
    >> Share

  235. MIYAZAWA S, Moriya S, Kokuba H, Hino H, et al
    Vitamin K2 induces non-apoptotic cell death along with autophagosome formation in breast cancer cell lines.
    Breast Cancer. 2019 Oct 17. pii: 10.1007/s12282-019-01012.
    >> Share

  236. MIRZAEI-PARSA MJ, Najafabadi MRH, Haeri A, Zahmatkeshan M, et al
    Preparation, characterization, and evaluation of the anticancer activity of artemether-loaded nano-niosomes against breast cancer.
    Breast Cancer. 2019 Oct 16. pii: 10.1007/s12282-019-01014.
    >> Share

  237. SUZUKI H, Seki A, Hosaka T, Matsumoto N, et al
    Effects of a structured group intervention on obesity among breast cancer survivors.
    Breast Cancer. 2019 Oct 15. pii: 10.1007/s12282-019-01013.
    >> Share

    September 2019
  238. ZALLOUM H, AbuThiab T, Hameduh T, AlBayyari S, et al
    Comparative anti-proliferative effects of potential HER2 inhibitors on a panel of breast cancer cell lines.
    Breast Cancer. 2019 Sep 26. pii: 10.1007/s12282-019-01011.
    >> Share

  239. XIE BJ, Zhu LN, Ma C, Li JB, et al
    A network meta-analysis on the efficacy of HER2-targeted agents in combination with taxane-containing regimens for treatment of HER2-positive metastatic breast cancer.
    Breast Cancer. 2019 Sep 16. pii: 10.1007/s12282-019-01007.
    >> Share

  240. ANDIC F, Miller AH, Brown G, Chu L, et al
    Instruments for determining clinically relevant fatigue in breast cancer patients during radiotherapy.
    Breast Cancer. 2019 Sep 6. pii: 10.1007/s12282-019-01008.
    >> Share

    August 2019
  241. DE SOUZA CUNHA N, Zomkowski K, Fernandes BL, Sacomori C, et al
    Physical symptoms and components of labor tasks associated with upper limb disability among working breast cancer survivors.
    Breast Cancer. 2019 Aug 27. pii: 10.1007/s12282-019-01004.
    >> Share

  242. KAWASE K, Yamashita H, Iwase H, Akashi-Tanaka S, et al
    Current conditions and issues of physicians and working conditions at institutions accredited by the Japanese Breast Cancer Society.
    Breast Cancer. 2019 Aug 22. pii: 10.1007/s12282-019-01005.
    >> Share

  243. LIN QY, Wang JQ, Wu LL, Zheng WE, et al
    miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Breast Cancer. 2019 Aug 13. pii: 10.1007/s12282-019-01002.
    >> Share

  244. NAITO Y, Kai Y, Ishikawa T, Fujita T, et al
    Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study.
    Breast Cancer. 2019 Aug 12. pii: 10.1007/s12282-019-01001.
    >> Share

  245. ZHANG R, Gao P, Ding J, Li Z, et al
    Assessment of significant procedures in multigene molecular detection for breast cancer in clinical laboratories: from variant detection to targeted therapy.
    Breast Cancer. 2019 Aug 6. pii: 10.1007/s12282-019-01000.
    >> Share

  246. IIOKA Y, Iwata T, Yamauchi H
    Developing a checksheet for breast cancer patients receiving endocrine therapy-examining reliability and validity.
    Breast Cancer. 2019 Aug 2. pii: 10.1007/s12282-019-00998.
    >> Share

  247. IGUCHI-MANAKA A, Okumura G, Ichioka E, Kiyomatsu H, et al
    High expression of soluble CD155 in estrogen receptor-negative breast cancer.
    Breast Cancer. 2019 Aug 1. pii: 10.1007/s12282-019-00999.
    >> Share

    July 2019
  248. NAKAGAWA A, Fujimoto H, Nagashima T, Sangai T, et al
    Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema.
    Breast Cancer. 2019 Jul 25. pii: 10.1007/s12282-019-00996.
    >> Share

  249. HOJO T, Masuda N, Iwamoto T, Niikura N, et al
    Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society.
    Breast Cancer. 2019 Jul 20. pii: 10.1007/s12282-019-00997.
    >> Share

  250. IIOKA Y, Iwata T, Yamauchi H
    Symptoms and QOL in breast cancer patients receiving hormone therapy in Japan.
    Breast Cancer. 2019 Jul 11. pii: 10.1007/s12282-019-00993.
    >> Share

  251. MOON G, Noh H, Cho IJ, Lee JI, et al
    Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence.
    Breast Cancer. 2019 Jul 6. pii: 10.1007/s12282-019-00994.
    >> Share

  252. YAO Z, Zheng X, Lu S, He Z, et al
    Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Breast Cancer. 2019 Jul 1. pii: 10.1007/s12282-019-00991.
    >> Share

    June 2019
  253. FURLANETTO J, von Minckwitz G, Lederer B, Mobus V, et al
    Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
    Breast Cancer. 2019 Jun 28. pii: 10.1007/s12282-019-00990.
    >> Share

  254. ZHAO C, Ling X, Li X, Hou X, et al
    MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Breast Cancer. 2019 Jun 26. pii: 10.1007/s12282-019-00989.
    >> Share

  255. ZHAI Q, Li H, Sun L, Yuan Y, et al
    Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Breast Cancer. 2019 Jun 13. pii: 10.1007/s12282-019-00988.
    >> Share

  256. DORRI S, Asadi F, Olfatbakhsh A, Kazemi A, et al
    A Systematic Review of Electronic Health (eHealth) interventions to improve physical activity in patients with breast cancer.
    Breast Cancer. 2019 Jun 12. pii: 10.1007/s12282-019-00982.
    >> Share

  257. SHIMIZU C, Sakata Y, Sakai R, Ikezawa H, et al
    Pharmacotherapy decision-making among patients with breast cancer in Japan: results of an online survey.
    Breast Cancer. 2019 Jun 8. pii: 10.1007/s12282-019-00986.
    >> Share

  258. SEKI H, Sakurai T, Mizuno S, Tokuda T, et al
    A novel nipple-areola complex involvement predictive index for indicating nipple-sparing mastectomy in breast cancer patients.
    Breast Cancer. 2019 Jun 8. pii: 10.1007/s12282-019-00987.
    >> Share

  259. CHENG X, Tan S, Duan F, Yuan Q, et al
    Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM.
    Breast Cancer. 2019 Jun 6. pii: 10.1007/s12282-019-00980.
    >> Share

  260. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
    Breast Cancer. 2019 Jun 5. pii: 10.1007/s12282-019-00984.
    >> Share

  261. BEYAN C, Beyan E
    Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus.
    Breast Cancer. 2019 Jun 3. pii: 10.1007/s12282-019-00983.
    >> Share

    May 2019
  262. HAO R, Liu Y, Du Q, Liu L, et al
    Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
    Breast Cancer. 2019 May 29. pii: 10.1007/s12282-019-00981.
    >> Share

  263. MANFUKU M, Nishigami T, Mibu A, Tanaka K, et al
    Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls.
    Breast Cancer. 2019 May 24. pii: 10.1007/s12282-019-00979.
    >> Share

  264. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
    Breast Cancer. 2019 May 24. pii: 10.1007/s12282-019-00970.
    >> Share

  265. TSUBOI K, Uematsu C, Yamaguchi Y, Niwa T, et al
    Tumor microenvironmental growth factors induce long-term estrogen deprivation resistance in breast cancer.
    Breast Cancer. 2019 May 22. pii: 10.1007/s12282-019-00978.
    >> Share

  266. USISKIN I, Li F, Irwin ML, Cartmel B, et al
    Association between pre-diagnosis BMI, physical activity, pathologic complete response, and chemotherapy completion in women treated with neoadjuvant chemotherapy for breast cancer.
    Breast Cancer. 2019 May 22. pii: 10.1007/s12282-019-00974.
    >> Share

  267. JONES LM, Stoner L, Brown C, Baldi JC, et al
    Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00975.
    >> Share

  268. LI N, Lv XH, Wang X, Wang RT, et al
    Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00976.
    >> Share

  269. ROBERTSON JFR, Jiang Z, Di Leo A, Ohno S, et al
    A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.
    Breast Cancer. 2019 May 11. pii: 10.1007/s12282-019-00973.
    >> Share

    April 2019
  270. MINAMI Y, Nishino Y, Kawai M, Tada H, et al
    Reproductive history and breast cancer survival: a prospective patient cohort study in Japan.
    Breast Cancer. 2019 Apr 15. pii: 10.1007/s12282-019-00972.
    >> Share

  271. GAO X, Liu X, Lu Y, Wang Y, et al
    PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Breast Cancer. 2019 Apr 15. pii: 10.1007/s12282-019-00966.
    >> Share

  272. SHIMADA S, Yoshida R, Nakashima E, Kitagawa D, et al
    Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Breast Cancer. 2019 Apr 12. pii: 10.1007/s12282-019-00971.
    >> Share

  273. PAPANIKOLAOU IG, Dimitrakakis C, Zagouri F, Marinopoulos S, et al
    Paving the way for changing perceptions in breast surgery: a systematic literature review focused on oncological and aesthetic outcomes of oncoplastic surgery for breast cancer.
    Breast Cancer. 2019 Apr 6. pii: 10.1007/s12282-019-00968.
    >> Share

  274. OMORI Y, Enatsu S, Cai Z, Ishiguro H, et al
    Patients' preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan.
    Breast Cancer. 2019 Apr 4. pii: 10.1007/s12282-019-00965.
    >> Share

  275. KATO F, Kudo K, Yamashita H, Baba M, et al
    Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
    Breast Cancer. 2019 Apr 1. pii: 10.1007/s12282-019-00969.
    >> Share

    March 2019
  276. LEE A, Jo S, Lee C, Shin HH, et al
    Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy.
    Breast Cancer. 2019 Mar 29. pii: 10.1007/s12282-019-00967.
    >> Share

  277. HIRAOKA E, Mimae T, Ito M, Kadoya T, et al
    Correction to: Breast cancer cell motility is promoted by 14-3-3gamma.
    Breast Cancer. 2019 Mar 29. pii: 10.1007/s12282-019-00964.
    >> Share

  278. PAN L, Ye C, Chen L, Tang W, et al
    Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer.
    Breast Cancer. 2019 Mar 19. pii: 10.1007/s12282-019-00962.
    >> Share

  279. KYRIAZOGLOU A, Zagouri F, Fotiou D, Dimitrakakis C, et al
    Discrepancies of current recommendations in breast cancer follow-up: a systematic review.
    Breast Cancer. 2019 Mar 18. pii: 10.1007/s12282-019-00963.
    >> Share

  280. MENESES-SANCHEZ P, Garcia-Hernandez SC, Porchia LM, Perez-Fuentes R, et al
    C677T and A1298C methylenetetrahydrofolate reductase polymorphisms and breast cancer susceptibility among Latinos: a meta-analysis.
    Breast Cancer. 2019 Mar 15. pii: 10.1007/s12282-019-00961.
    >> Share

  281. FUKUI K, Masumoto N, Shiroma N, Kanou A, et al
    Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer.
    Breast Cancer. 2019 Mar 13. pii: 10.1007/s12282-019-00958.
    >> Share

  282. HIRAOKA E, Mimae T, Ito M, Kadoya T, et al
    Breast cancer cell motility is promoted by 14-3-3gamma.
    Breast Cancer. 2019 Mar 4. pii: 10.1007/s12282-019-00957.
    >> Share

    February 2019
  283. KOTANI H, Ito H, Kuwahara K, Kuzushima K, et al
    Impact of germinal center-associated nuclear protein polymorphisms on breast cancer risk and prognosis in a Japanese population.
    Breast Cancer. 2019 Feb 27. pii: 10.1007/s12282-019-00956.
    >> Share

  284. LAI HL, Chen CI, Lu CY, Yao YC, et al
    Relationships among personality, coping, and concurrent health-related quality of life in women with breast cancer.
    Breast Cancer. 2019 Feb 12. pii: 10.1007/s12282-019-00954.
    >> Share

  285. ISHIGURO H, Ohno S, Yamamoto Y, Takao S, et al
    Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer.
    Breast Cancer. 2019 Feb 7. pii: 10.1007/s12282-019-00952.
    >> Share

    January 2019
  286. BI Z, Liu J, Chen P, Liu Y, et al
    Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
    Breast Cancer. 2019 Jan 21. pii: 10.1007/s12282-018-00934.
    >> Share

  287. LIU L, Hu Y, Zhang S, Li X, et al
    Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer.
    Breast Cancer. 2019 Jan 8. pii: 10.1007/s12282-018-00939.
    >> Share

  288. UCHIUMI K, Tsuboi K, Sato N, Ito T, et al
    Cancer stem-like properties of hormonal therapy-resistant breast cancer cells.
    Breast Cancer. 2019 Jan 4. pii: 10.1007/s12282-018-00944.
    >> Share

  289. SHARMA R
    Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016.
    Breast Cancer. 2019 Jan 2. pii: 10.1007/s12282-018-00941.
    >> Share

    December 2018
  290. KHADEMALHOSSEINI M, Arababadi MK
    Toll-like receptor 4 and breast cancer: an updated systematic review.
    Breast Cancer. 2018 Dec 12. pii: 10.1007/s12282-018-00935.
    >> Share

    November 2018
  291. KANAYA N, Tanakaya K, Yamasaki R, Arata T, et al
    Clinicopathological features of breast cancer in Japanese female patients with Lynch syndrome.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0931.
    >> Share

  292. WANG R, Li J, Yin C, Zhao D, et al
    Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0924.
    >> Share

  293. ABBAS S, Siddique A, Shahid N, Khan RT, et al
    Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
    Breast Cancer. 2018 Nov 14. pii: 10.1007/s12282-018-0932.
    >> Share

    October 2018
  294. HU K, He P, Peng Q, Zhong X, et al
    OFS plus AI or SERM vs. SERM alone in premenopausal women with hormone receptor-positive breast cancer: a prospective cohort study using the real-world database.
    Breast Cancer. 2018 Oct 26. pii: 10.1007/s12282-018-0929.
    >> Share

  295. DEN OUDEN MEM, Pelgrum-Keurhorst MN, Uitdehaag MJ, De Vocht HM, et al
    Intimacy and sexuality in women with breast cancer: professional guidance needed.
    Breast Cancer. 2018 Oct 25. pii: 10.1007/s12282-018-0927.
    >> Share

  296. RANGEL J, Tomas MT, Fernandes B
    Physical activity and physiotherapy: perception of women breast cancer survivors.
    Breast Cancer. 2018 Oct 25. pii: 10.1007/s12282-018-0928.
    >> Share

  297. YAGI T, Fujiishi K, Hasegawa A, Otsuka T, et al
    Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.
    Breast Cancer. 2018 Oct 22. pii: 10.1007/s12282-018-0918.
    >> Share

  298. LIU M, Zhou S, Wang J, Zhang Q, et al
    Identification of genes associated with survival of breast cancer patients.
    Breast Cancer. 2018 Oct 19. pii: 10.1007/s12282-018-0926.
    >> Share

  299. PALUMBO I, Mariucci C, Falcinelli L, Perrucci E, et al
    Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
    Breast Cancer. 2018 Oct 19. pii: 10.1007/s12282-018-0923.
    >> Share

  300. IIDA M, Tsuboi K, Niwa T, Ishida T, et al
    Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Breast Cancer. 2018 Oct 16. pii: 10.1007/s12282-018-0922.
    >> Share

  301. KWAPISZ D
    Oligometastatic breast cancer.
    Breast Cancer. 2018 Oct 15. pii: 10.1007/s12282-018-0921.
    >> Share

  302. TSURUTANI J, Sakata Y, Matsuoka T
    Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.
    Breast Cancer. 2018 Oct 15. pii: 10.1007/s12282-018-0919.
    >> Share

  303. SUZUKI E, Sugimoto M, Kawaguchi K, Pu F, et al
    Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.
    Breast Cancer. 2018 Oct 13. pii: 10.1007/s12282-018-0920.
    >> Share

  304. HASHEMI ZS, Forouzandeh Moghadam M, Khalili S, Ghavami M, et al
    Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
    Breast Cancer. 2018 Oct 3. pii: 10.1007/s12282-018-0915.
    >> Share

    September 2018
  305. WANG X, Jia M, Li Y, Bao Y, et al
    Validation of an information-motivation-behavioral skills model of upper limb functional exercise adherence among Chinese postoperative patients with breast cancer.
    Breast Cancer. 2018 Sep 27. pii: 10.1007/s12282-018-0911.
    >> Share

  306. NAKASHIMA K, Uematsu T, Takahashi K, Nishimura S, et al
    Does breast cancer growth rate really depend on tumor subtype? Measurement of tumor doubling time using serial ultrasonography between diagnosis and surgery.
    Breast Cancer. 2018 Sep 26. pii: 10.1007/s12282-018-0914.
    >> Share

  307. MA Y, Wang Y, Song B
    Griffipavixanthone induces apoptosis of human breast cancer MCF-7 cells in vitro.
    Breast Cancer. 2018 Sep 26. pii: 10.1007/s12282-018-0912.
    >> Share

  308. ZOHNY SF, Al-Malki AL, Zamzami MA, Choudhry H, et al
    p21(Waf1/Cip1): its paradoxical effect in the regulation of breast cancer.
    Breast Cancer. 2018 Sep 25. pii: 10.1007/s12282-018-0913.
    >> Share

  309. ISHIGAMI E, Sakakibara M, Sakakibara J, Masuda T, et al
    Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer.
    Breast Cancer. 2018 Sep 22. pii: 10.1007/s12282-018-0910.
    >> Share

  310. TALIMA S, Kassem H, Kassem N
    Correction to: Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Breast Cancer. 2018 Sep 21. pii: 10.1007/s12282-018-0909.
    >> Share

  311. OKUMATSU K, Tsujimoto T, Wakaba K, Seki A, et al
    Correction to: Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients.
    Breast Cancer. 2018 Sep 17. pii: 10.1007/s12282-018-0902.
    >> Share

  312. KIKAWA Y, Hatachi Y, Rumpold G, Tokiwa M, et al
    Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
    Breast Cancer. 2018 Sep 7. pii: 10.1007/s12282-018-0905.
    >> Share

  313. TALIMA S, Kaseem H, Kaseem N
    Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Breast Cancer. 2018 Sep 6. pii: 10.1007/s12282-018-0904.
    >> Share

  314. ABU-KHALAF M, Muralikrishnan S, Hatzis C, Canchi D, et al
    Breast cancer patients with brain metastasis undergoing GKRS.
    Breast Cancer. 2018 Sep 4. pii: 10.1007/s12282-018-0903.
    >> Share

  315. AYGIN D, Cengiz H
    Life quality of patients who underwent breast reconstruction after prophylactic mastectomy: systematic review.
    Breast Cancer. 2018;25:497-505.
    >> Share

  316. SUGHAYER M, Alaaraj R, Alsughayer A
    Applying new Magee equations for predicting the Oncotype Dx recurrence score.
    Breast Cancer. 2018;25:597-604.
    >> Share

  317. SAKAMOTO N, Fukuma E, Tsunoda Y, Teraoka K, et al
    Evaluation of the dislocation and long-term sonographic detectability of a hydrogel-based breast biopsy site marker.
    Breast Cancer. 2018;25:575-582.
    >> Share

  318. ADACHI Y, Sawaki M, Hattori M, Yoshimura A, et al
    Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Breast Cancer. 2018;25:560-565.
    >> Share

  319. GORCZYNSKI RM, Erin N, Maqbool T, Gorczynski CP, et al
    Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions.
    Breast Cancer. 2018;25:547-559.
    >> Share

    August 2018
  320. AYGIN D, Bozdemir H
    Exposure to violence in breast cancer patients: systematic review.
    Breast Cancer. 2018 Aug 22. pii: 10.1007/s12282-018-0900.
    >> Share

  321. NAGASAKA K, Satake H, Ishigaki S, Kawai H, et al
    Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Breast Cancer. 2018 Aug 1. pii: 10.1007/s12282-018-0899.
    >> Share

    July 2018
  322. ALTUNDAG K
    Younger breast cancer patients under the age of 35 might have a better disease-free survival if they received ovarian function suppression more than 3 years.
    Breast Cancer. 2018 Jul 28. pii: 10.1007/s12282-018-0897.
    >> Share

  323. NAKATSUKASA K, Koyama H, Ouchi Y, Ono H, et al
    Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
    Breast Cancer. 2018 Jul 27. pii: 10.1007/s12282-018-0896.
    >> Share

  324. AFTAB A, Shahzad S, Hussain HMJ, Khan R, et al
    CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis.
    Breast Cancer. 2018 Jul 23. pii: 10.1007/s12282-018-0894.
    >> Share

  325. NOGUCHI E, Tamura K, Hattori M, Horiguchi J, et al
    Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study.
    Breast Cancer. 2018 Jul 23. pii: 10.1007/s12282-018-0887.
    >> Share

  326. LIU C, Liu Y, Chen L, Zhang M, et al
    Quantitative proteome and lysine succinylome analyses provide insights into metabolic regulation in breast cancer.
    Breast Cancer. 2018 Jul 18. pii: 10.1007/s12282-018-0893.
    >> Share

  327. OKUMATSU K, Tsujimoto T, Wakaba K, Seki A, et al
    Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients.
    Breast Cancer. 2018 Jul 10. pii: 10.1007/s12282-018-0889.
    >> Share

  328. MA D, Chen C, Wu J, Wang H, et al
    Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Breast Cancer. 2018 Jul 5. pii: 10.1007/s12282-018-0891.
    >> Share

  329. TOKUNAGA E, Fujita A, Takizawa K, Baba K, et al
    CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Breast Cancer. 2018 Jul 3. pii: 10.1007/s12282-018-0888.
    >> Share

  330. MACHIDA Y, Shimauchi A, Igarashi T, Hoshi K, et al
    Preoperative breast MRI: reproducibility and significance of findings relevant to nipple-areolar complex involvement.
    Breast Cancer. 2018;25:456-463.
    >> Share

  331. SAIMURA M, Koga K, Anan K, Mitsuyama S, et al
    Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.
    Breast Cancer. 2018;25:470-478.
    >> Share

    June 2018
  332. PENG X, Yan B, Shen Y
    MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Breast Cancer. 2018 Jun 27. pii: 10.1007/s12282-018-0881.
    >> Share

  333. LIU L, Yin B, Yi Z, Liu X, et al
    Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs.
    Breast Cancer. 2018 Jun 14. pii: 10.1007/s12282-018-0880.
    >> Share

  334. TAKABATAKE D, Kajiwara Y, Ohtani S, Itano Y, et al
    The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
    Breast Cancer. 2018 Jun 11. pii: 10.1007/s12282-018-0877.
    >> Share

  335. TOYAMA T, Yoshimura A, Hayashi T, Kobayashi N, et al
    A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.
    Breast Cancer. 2018 Jun 8. pii: 10.1007/s12282-018-0879.
    >> Share

    May 2018
  336. LOUHICHI T, Ziadi S, Saad H, Dhiab MB, et al
    Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
    Breast Cancer. 2018 May 29. pii: 10.1007/s12282-018-0875.
    >> Share

  337. SAJI S
    The long and winding road for overcoming resistance to hormone therapy in breast cancer.
    Breast Cancer. 2018 May 28. pii: 10.1007/s12282-018-0876.
    >> Share

  338. GAO L, Li SC
    Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation.
    Breast Cancer. 2018 May 25. pii: 10.1007/s12282-018-0872.
    >> Share

  339. WEN L, Liu L, Wen L, Yu T, et al
    Artesunate promotes G2/M cell cycle arrest in MCF7 breast cancer cells through ATM activation.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0873.
    >> Share

  340. OSTAPCHUK YO, Perfilyeva YV, Kustova EA, Urazalieva NT, et al
    Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0874.
    >> Share

  341. LEE SB, Sohn G, Kim J, Chung IY, et al
    Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study.
    Breast Cancer. 2018 May 21. pii: 10.1007/s12282-018-0869.
    >> Share

  342. TAKADA M, Takeuchi M, Suzuki E, Sato F, et al
    Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence.
    Breast Cancer. 2018 May 9. pii: 10.1007/s12282-018-0868.
    >> Share

  343. JAMAN MS, Sayeed MA
    Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives.
    Breast Cancer. 2018 May 3. pii: 10.1007/s12282-018-0866.
    >> Share

  344. GLOWACKA-MROTEK I, Sowa M, Nowikiewicz T, Siedlecki Z, et al
    Foot posture in female patients 5 years after breast-conserving surgery: a case-control study.
    Breast Cancer. 2018;25:325-333.
    >> Share

    April 2018
  345. KWAPISZ D
    Cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive early breast cancer: preliminary results and ongoing studies.
    Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0864.
    >> Share

  346. SAKAI H, Tsurutani J, Iwasa T, Komoike Y, et al
    HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.
    Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0861.
    >> Share

  347. WANG NN, Yang ZJ, Wang X, Chen LX, et al
    A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
    Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0863.
    >> Share

  348. AOYAGI T, Takabe K, Tamanuki T, Matsubara H, et al
    Pseudocirrhosis after chemotherapy in breast cancer, case reports.
    Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0865.
    >> Share

  349. OHASHI R, Nagao M, Nakamura I, Okamoto T, et al
    Improvement in diagnostic performance of breast cancer: comparison between conventional digital mammography alone and conventional mammography plus digital breast tomosynthesis.
    Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0859.
    >> Share

  350. NAZARI SS, Mukherjee P
    An overview of mammographic density and its association with breast cancer.
    Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0857.
    >> Share

  351. LI Q, Gao H, Zhou S, Liao Y, et al
    LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-beta1 and downregulating PHGDH.
    Breast Cancer. 2018 Apr 6. pii: 10.1007/s12282-018-0858.
    >> Share

  352. IWASE M, Sawaki M, Hattori M, Yoshimura A, et al
    Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
    Breast Cancer. 2018 Apr 4. pii: 10.1007/s12282-018-0856.
    >> Share

    March 2018
  353. SASADA S, Shien T, Iwata H
    Current status of postmastectomy radiation therapy in T1-2 breast cancer with limited positive lymph nodes in Japan: Japan Clinical Oncology Group Survey.
    Breast Cancer. 2018 Mar 23. pii: 10.1007/s12282-018-0855.
    >> Share

  354. WAKABAYASHI H, Hamaguchi T, Nagao N, Kato S, et al
    Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
    Breast Cancer. 2018 Mar 19. pii: 10.1007/s12282-018-0853.
    >> Share

  355. ZHANG JM, Wei K, Jiang M
    OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
    Breast Cancer. 2018 Mar 13. pii: 10.1007/s12282-018-0844.
    >> Share

  356. YOSHIMURA A, Okumura S, Sawaki M, Hattori M, et al
    Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
    Breast Cancer. 2018 Mar 8. pii: 10.1007/s12282-018-0850.
    >> Share

  357. KA WH, Cho SK, Chun BN, Byun SY, et al
    The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Breast Cancer. 2018 Mar 7. pii: 10.1007/s12282-018-0849.
    >> Share

    February 2018
  358. RAMOS-ESQUIVEL A, Hernandez-Steller H, Savard MF, Landaverde DU, et al
    Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials.
    Breast Cancer. 2018 Feb 22. pii: 10.1007/s12282-018-0848.
    >> Share

  359. NOGUCHI S, Ellis MJ, Robertson JFR, Thirlwell J, et al
    Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON).
    Breast Cancer. 2018 Feb 15. pii: 10.1007/s12282-018-0838.
    >> Share

  360. MASUDA N, Toi M, Yamamoto N, Iwata H, et al
    Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicent
    Breast Cancer. 2018 Feb 14. pii: 10.1007/s12282-018-0839.
    >> Share

  361. CHEN W, Lv X, Xu X, Gao X, et al
    Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer.
    Breast Cancer. 2018 Feb 13. pii: 10.1007/s12282-018-0846.
    >> Share

  362. OHTANI S, Nakayama T, Yoshinami T, Watanabe KI, et al
    Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
    Breast Cancer. 2018 Feb 12. pii: 10.1007/s12282-018-0843.
    >> Share

  363. SURYAVANSHI M, Mehta A, Jaipuria J, Kumar D, et al
    Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients.
    Breast Cancer. 2018 Feb 9. pii: 10.1007/s12282-018-0840.
    >> Share

  364. ZOU L, Liu FH, Shen PP, Hu Y, et al
    The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Breast Cancer. 2018 Feb 3. pii: 10.1007/s12282-018-0830.
    >> Share

  365. IWATA H
    Clinical development of CDK4/6 inhibitor for breast cancer.
    Breast Cancer. 2018 Feb 1. pii: 10.1007/s12282-017-0827.
    >> Share

    January 2018
  366. WANG Y, Wang J, Long F, Wang N, et al
    Correlation of FANCM expression with clinical factors in luminal B breast cancer.
    Breast Cancer. 2018 Jan 31. pii: 10.1007/s12282-018-0841.
    >> Share

  367. KHAN RT, Siddique A, Shahid N, Khokher S, et al
    Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
    Breast Cancer. 2018 Jan 24. pii: 10.1007/s12282-018-0837.
    >> Share

  368. NGUYEN-THU H, Hanaoka H, Nakajima T, Yamaguchi A, et al
    Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and (18)F-FDG-PET.
    Breast Cancer. 2018 Jan 22. pii: 10.1007/s12282-018-0834.
    >> Share

  369. OZAKI Y, Tanabe Y, Tamura N, Ogura T, et al
    Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.
    Breast Cancer. 2018 Jan 22. pii: 10.1007/s12282-018-0836.
    >> Share

  370. YANG ZJ, Yu Y, Chi JR, Guan M, et al
    The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.
    Breast Cancer. 2018 Jan 20. pii: 10.1007/s12282-018-0833.
    >> Share

  371. HABYARIMANA T, Attaleb M, Mazarati JB, Bakri Y, et al
    Detection of human papillomavirus DNA in tumors from Rwandese breast cancer patients.
    Breast Cancer. 2018 Jan 19. pii: 10.1007/s12282-018-0831.
    >> Share

  372. INARI H, Shimizu S, Suganuma N, Yoshida T, et al
    Correction to: A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women.
    Breast Cancer. 2018 Jan 10. pii: 10.1007/s12282-018-0832.
    >> Share

  373. PIVOT X, Im SA, Guo M, Marme F, et al
    Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine.
    Breast Cancer. 2018 Jan 4. pii: 10.1007/s12282-017-0826.
    >> Share

    December 2017
  374. PIERRISNARD C, Baciuchka M, Mancini J, Rathelot P, et al
    Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations.
    Breast Cancer. 2017 Dec 29. pii: 10.1007/s12282-017-0828.
    >> Share

  375. ATTALLAH AM, El-Far M, Abdelrazek MA, Omran MM, et al
    HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer.
    Breast Cancer. 2017 Dec 28. pii: 10.1007/s12282-017-0829.
    >> Share

  376. SHIMOI T, Yoshida M, Kitamura Y, Yoshino T, et al
    TERT promoter hotspot mutations in breast cancer.
    Breast Cancer. 2017 Dec 8. pii: 10.1007/s12282-017-0825.
    >> Share

  377. TSUDA B, Miyamoto A, Yokoyama K, Ogiya R, et al
    B-cell populations are expanded in breast cancer patients compared with healthy controls.
    Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0824.
    >> Share

  378. DORFEL S, Steffens CC, Meyer D, Tesch H, et al
    Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.
    Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0823.
    >> Share

  379. HE J, Chen Y, Cai L, Li Z, et al
    UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer.
    Breast Cancer. 2017 Dec 1. pii: 10.1007/s12282-017-0820.
    >> Share

    November 2017
  380. INOUE H, Horii R, Ito Y, Iwase T, et al
    Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.
    Breast Cancer. 2017 Nov 28. pii: 10.1007/s12282-017-0822.
    >> Share

  381. ZHANG ZL, Jiang QC, Wang SR
    Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Breast Cancer. 2017 Nov 27. pii: 10.1007/s12282-017-0821.
    >> Share

  382. ZHAO Q, Song W, He DY, Li Y, et al
    Identification of key gene modules and pathways of human breast cancer by co-expression analysis.
    Breast Cancer. 2017 Nov 23. pii: 10.1007/s12282-017-0817.
    >> Share

  383. HATTORI M, Ishiguro H, Masuda N, Yoshimura A, et al
    Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study.
    Breast Cancer. 2017 Nov 20. doi: 10.1007/s12282-017-0815.
    >> Share

  384. KASSEM L, Shohdy KS, Lasheen S, Abdel-Rahman O, et al
    Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis.
    Breast Cancer. 2017 Nov 16. doi: 10.1007/s12282-017-0818.
    >> Share

  385. WANG R, Li J, Zhao Y, Li Y, et al
    Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
    Breast Cancer. 2017 Nov 14. doi: 10.1007/s12282-017-0816.
    >> Share

  386. ADHAMI M, Haghdoost AA, Sadeghi B, Malekpour Afshar R, et al
    Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Breast Cancer. 2017 Nov 3. doi: 10.1007/s12282-017-0814.
    >> Share

  387. SHIGEMATSU H, Ozaki S, Yasui D, Zaitsu J, et al
    Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0811.
    >> Share

  388. HARAO M, Ando J, Kamata H, Hoshi N, et al
    Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0813.
    >> Share

    October 2017
  389. ARAKI K, Miyoshi Y
    Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
    Breast Cancer. 2017 Oct 31. doi: 10.1007/s12282-017-0812.
    >> Share

  390. KHPAL M, Miller JRC, Petrovic Z, Hassanally D, et al
    Local anesthetic delivery via surgical drain provides improved pain control versus direct skin infiltration following axillary node dissection for breast cancer.
    Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0810.
    >> Share

  391. REGEV-AVRAHAM Z, Baron-Epel O, Hammond SK, Keinan-Boker L, et al
    Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case-control study.
    Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0809.
    >> Share

  392. OGITA M, Nagura N, Kawamori J, In R, et al
    Risk factors for complications among breast cancer patients treated with post-mastectomy radiotherapy and immediate tissue-expander/permanent implant reconstruction: a retrospective cohort study.
    Breast Cancer. 2017 Oct 19. doi: 10.1007/s12282-017-0808.
    >> Share

  393. TOYODA Y, Tabuchi T, Nakayama T, Hojo S, et al
    Trends in the clinical stage distribution of breast cancer in Osaka, Japan.
    Breast Cancer. 2017 Oct 12. doi: 10.1007/s12282-017-0807.
    >> Share

    September 2017
  394. ALTUNDAG K
    Questions about lower inner zone tumors in early-stage breast cancer.
    Breast Cancer. 2017 Sep 14. doi: 10.1007/s12282-017-0801.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016